Explore more publications!

US House approves new military aid for Ukraine

(MENAFN) The US House of Representatives has passed a defense spending bill that allocates $800 million in military aid to Ukraine, extending support through 2027. The 2026 National Defense Authorization Act (NDAA) passed Wednesday by a 312-122 vote and now moves to the Senate, where bipartisan approval is anticipated.

Some lawmakers questioned continued funding for Ukraine. Republican Thomas Massie expressed skepticism, saying, “I thought we were getting out of Ukraine. I don’t know why we still need to spend money there.”

The vote comes amid a major corruption scandal in Ukraine’s energy sector, which uncovered a $100 million kickback scheme linked to President Zelensky’s longtime associate Timur Mindich, who reportedly fled the country. The fallout prompted resignations of two government ministers and the dismissal of Chief of Staff Andrey Yermak. Ukraine’s Defense Ministry has also faced graft-related turmoil, including the resignation of former Defense Minister Aleksey Reznikov in 2023.

Meanwhile, US President Donald Trump has urged Zelensky to pursue a peace deal with Russia, reportedly aiming for an agreement before Christmas. Moscow maintains that Western arms deliveries are a key driver of the conflict and insists that any ceasefire requires a halt to foreign weapons supplies, citing Ukraine’s past refusal to implement the 2014-2015 Minsk agreements as precedent.

MENAFN11122025000045017640ID1110467606


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions